HerbParlor
Dandelion (Taraxacum officinale)Emerging evidence

Dandelion

Taraxacum officinale

Overview

At a glance

Dandelion (Taraxacum officinale) is an Asteraceae botanical represented by root, leaf/herb and root + herb preparations. Human clinical evidence is very limited and preparation-dependent, with one small single-day study of a leaf extract and broader reviews that include substantial preclinical literature.

Key takeaway

Dandelion is not one uniform intervention. Root, leaf/herb and root + herb preparations can differ in composition and evidence relevance. A small human study of a leaf extract should not be treated as evidence for root preparations, root + herb products or every commercial Dandelion product, and traditional use is not proof of efficacy.

Common uses studied

Root preparations in traditional herbal-medicine contextsLeaf/herb preparations and extractsRoot + herb preparations in traditional-use frameworksLimited human research on a leaf extract and a diuretic outcome

Start here

What are you trying to figure out?

Pick the question closest to yours. Each card jumps to the relevant part of this profile or an existing HerbParlor tool — no sponsored rankings, no hidden ordering.

Understand the herbExplore the evidenceUnderstand formsCheck safetyEvaluate a supplementCompare options

Identity

What is this herb?

Family

Asteraceae

Species

Taraxacum officinale

Common names

DandelionCommon dandelion

Plant parts used

RootLeaf / herbRoot + herb

Geographic context

Dandelion is a widely known Taraxacum botanical. The cited taxonomic source records taxonomic complexity within the genus, so botanical identity should be confirmed from the source or product rather than inferred from the common name alone.

Identification notes

This profile uses Taraxacum officinale as the canonical identity. A label that says only “dandelion” does not establish the species, plant part or preparation. Root, leaf/herb and root + herb material should be recorded separately because evidence for one is not automatically evidence for the others.

Background

Traditional context

Traditions

European herbal-medicine contexts

Historical uses

Traditional-use context for Dandelion root preparationsTraditional-use context for root + herb preparations

The EMA monographs describe traditional-use frameworks for specific root and root + herb preparations. Traditional use and the existence of a monograph are historical or regulatory context, not proof that Dandelion is effective for a disease or that one preparation is equivalent to another.

Preparations

Forms & preparations

Forms

Root tea or infusionRoot powderRoot extractLeaf/herb extractRoot + herb preparationCapsule or tablet when the underlying plant part is disclosedLiquid preparation when explicitly disclosed

Preparation methods

Dried root prepared as a tea, infusion or other preparation where explicitly describedDried root powder where the plant part is identifiedLeaf/herb extract, including the ethanolic leaf extract studied in the small human trialRoot + herb preparation where both plant parts are explicitly identifiedCapsule, tablet or liquid product only when its underlying material and preparation are disclosed

What changes between forms

  • Root, leaf/herb and root + herb are distinct plant-part preparations and should not be treated as interchangeable.
  • The small human study examined a specific leaf extract over a single day; it did not establish effects for root or root + herb preparations.
  • Root monograph context should not be transferred to leaf/herb products, and root + herb monograph context should not be transferred to root-only or leaf-only products.
  • Tea, powder, capsule, tablet, extract and liquid products may differ in plant part, extraction method, composition and amount.
  • Phytochemical, laboratory and animal findings do not establish clinical efficacy for a commercial Dandelion product.

Human evidence is preparation-specific. The directly cited human study concerns a leaf extract, while the cited monographs concern root or root + herb preparations and the reviews cover mixed human, animal and in vitro literature. The word “Dandelion” alone is not enough to identify the relevant intervention.

Research

Research Explorer

Each question summarizes what human research has examined, how it was studied, and the main limitations — not a treatment recommendation.

What did the small human study of Dandelion leaf actually examine?

Population

Human subjects studied over a single day in a small study of a specific Taraxacum officinale leaf extract.

Intervention

An ethanolic extract of Taraxacum officinale leaf (folium) as described in the 2009 study.

Comparator

Study-specific observations and comparator context as reported in the original study; this was not a general test of all Dandelion preparations.

Outcomes studied

Diuretic or urinary outcome over a single dayStudy-specific tolerability or safety observations where assessed

Evidence assessment

The 2009 human study reported a diuretic effect for a specific ethanolic Dandelion leaf extract over a single day. Its small size, short duration, preparation-specific design and population limit interpretation. It does not establish Dandelion as a proven diuretic treatment and must not be generalized to root, root + herb or every commercial product.

Limitations

  • Small number of human subjects
  • Single-day follow-up
  • Specific ethanolic leaf extract rather than an unspecified Dandelion product
  • Limited basis for conclusions about long-term effects, safety or clinical treatment
  • Findings should not be generalized to root or root + herb preparations

Sources

What does the root preparation evidence actually establish?

Population

Not a direct efficacy population in this profile; the cited EMA record describes a traditional herbal-medicine framework for Dandelion root.

Intervention

Taraxacum officinale root (radix) preparations described in the EMA herbal monograph.

Comparator

Not applicable to the traditional-use monograph context.

Outcomes studied

Traditional-use indications and preparation context

Evidence assessment

The EMA root monograph provides preparation-specific traditional-use context. It does not independently establish clinical efficacy, a dosage recommendation, long-term safety or equivalence with leaf/herb, root + herb or other commercial preparations.

Limitations

  • Traditional-use classification is not proof of efficacy
  • Root context should not be generalized to leaf/herb preparations
  • Monograph context does not establish efficacy for every commercial product

Sources

What does the root + herb preparation evidence actually establish?

Population

Not a direct efficacy population in this profile; the cited EMA record describes a traditional herbal-medicine framework for a root + herb preparation.

Intervention

Taraxacum radix cum herba, meaning a preparation containing Dandelion root and herb, as described in the EMA monograph.

Comparator

Not applicable to the traditional-use monograph context.

Outcomes studied

Traditional-use indications and combined-preparation context

Evidence assessment

The EMA root + herb monograph describes a combined-preparation traditional-use framework. It does not establish that the combined preparation is effective for a disease, that it is equivalent to root-only or leaf-only material, or that its context applies to every commercial Dandelion product.

Limitations

  • Root + herb is a distinct preparation from root-only and leaf-only material
  • Traditional-use classification is not proof of efficacy
  • Preparation details and product identity may differ across products

Sources

What does the broader review and preclinical literature show?

Population

Mixed literature including limited human clinical evidence and animal or in vitro research across Dandelion materials and proposed uses.

Intervention

Dandelion or Taraxacum preparations as described in each individual review; plant part and preparation vary and must be checked at source level.

Comparator

Varies by review and underlying study.

Outcomes studied

Evidence gradingPhytochemical and pharmacological activityBiological or mechanistic outcomes

Evidence assessment

The cited reviews include human, animal and in vitro material, with much of the support being preclinical and human clinical evidence limited. Phytochemical, laboratory, mechanistic or animal findings can help describe biological activity, but they do not establish clinical efficacy or validate a specific commercial Dandelion preparation.

Limitations

  • Human clinical evidence is limited
  • Mixed evidence types cannot be treated as equivalent
  • Plant parts and preparations vary across the literature
  • Preclinical findings do not establish benefit in people

Sources

Why must root, leaf/herb and root + herb evidence be interpreted separately?

Population

People comparing Dandelion products with the specific plant parts and preparations represented in the cited literature.

Intervention

Root, leaf/herb and root + herb preparations, including teas, powders, extracts and products whose underlying material is disclosed.

Comparator

Not applicable.

Outcomes studied

Plant-part identityPreparation identityEvidence interpretability

Evidence assessment

Root, leaf/herb and root + herb are different interventions. The single-day human leaf-extract finding does not validate a root tea or root powder; root monograph context does not validate a leaf extract; and root + herb context does not validate either component on its own. Evidence must be matched to the identified material and preparation.

Limitations

  • Commercial labels may omit the plant part or preparation
  • No single uniform Dandelion intervention is used across the sources
  • Product-level equivalence cannot be assumed from the common name alone

Sources

Latest evidence

Recently published research

Searching Europe PMC…

Looking for recent publications…

These publications are automatically discovered from Europe PMC. They have not necessarily been independently reviewed by HerbParlor and are not automatically incorporated into the evidence assessment.

Evidence

Evidence

Human clinical evidence for Dandelion is very limited and preparation-dependent. One small, single-day human study examined an ethanolic leaf extract and reported a diuretic outcome. The other cited material includes traditional-use monographs and reviews containing limited human evidence alongside animal, in vitro, phytochemical and mechanistic findings. This does not establish Dandelion as a proven treatment for a disease, and evidence from one leaf extract, root preparation or root + herb preparation must not be generalized to every commercial product.

Evidence tier

Emerging

Confidence

Overall confidence is emerging but limited. Important uncertainties concern species identity, plant part, preparation, extraction method, amount, duration, population, study quality and whether a commercial product resembles the intervention described in the source. No dosage recommendation is made.

Last evidence review

2026-09-20

Where the evidence is strongest

Clear identification of the small, single-day human study as leaf-extract evidence rather than evidence for Dandelion generallyPreparation-aware distinction between root, leaf/herb and root + herb materialsDistinction between traditional-use, human, preclinical and phytochemical literature

How to interpret this

Dandelion evidence should be interpreted at the level of the identified Taraxacum botanical, plant part, preparation, amount, outcome and study design. The small human study concerns a specific leaf extract over a single day; the root and root + herb monographs provide traditional-use context; and the reviews include substantial preclinical material. None of these sources establishes Dandelion as a proven treatment for a disease, a universal diuretic, or an equivalent intervention across products.

Automatic evidence update

Since the last editorial review

Checking Europe PMC…
Checking evidence

Checking for publications published since the last editorial evidence review…

This automatic update detects newly published literature; it does not replace HerbParlor's editorial evidence assessment. Review status is an automatic triage signal. Curated HerbParlor evidence is unchanged until editorial review.

Boundaries

What the evidence does NOT establish

Areas with limited evidence

  • Claims that Dandelion is an established diuretic or treatment for any disease
  • Generalization from the single-day leaf-extract study to root, root + herb or other products
  • Generalization from an EMA root or root + herb monograph to every Dandelion preparation
  • Clinical conclusions based only on phytochemical, laboratory, animal or mechanistic findings

Evidence gaps

  • Larger and longer well-described human studies with clinically meaningful outcomes
  • Direct evidence for clearly identified root and root + herb preparations
  • Consistent reporting of species, plant part, preparation, extraction method and amount
  • Independent confirmation of preparation-specific findings and better long-term safety assessment

Common misconceptions

  • Traditional use is not proof of efficacy.
  • A traditional-use monograph is not the same as clinical proof.
  • Root, leaf/herb and root + herb are not interchangeable preparations.
  • A small single-day leaf-extract study does not establish Dandelion as a treatment.
  • Phytochemical, laboratory and animal findings do not establish clinical efficacy.
  • One Dandelion extract does not validate every tea, powder, capsule, liquid or combination product.

Safety

Safety & interactions

General considerations

  • Safety evidence is limited across the range of Dandelion plant parts and preparations; safety findings from one preparation should not automatically be applied to another.
  • The cited human study was short and single-day, so it does not establish long-term safety for leaf extract, root, root + herb or commercial products.
  • Product labels may omit the plant part, extraction method or complete composition, increasing uncertainty about what has been studied.
  • The existence of a traditional-use monograph does not establish a complete safety profile for every Dandelion product.

Pregnancy & nursing

  • Safety during pregnancy and breastfeeding is not established for every Dandelion preparation, particularly concentrated extracts.
  • People who are pregnant or breastfeeding should discuss a specific product with a qualified healthcare professional.

Medication interactions to be aware of

Specific interaction information is not established across Dandelion plant parts and preparations. People taking medicines, including diuretics, should discuss a specific product with a qualified healthcare professional rather than infer safety from traditional use or a short study.

Condition considerations

  • People with a medical condition or persistent symptoms should not use this profile as a substitute for diagnosis or established care.
  • Uncertainty is greater when a product does not identify its botanical identity, plant part, preparation or amount.

Duration

  • Long-term safety is not established for every Dandelion root, leaf/herb, root + herb or concentrated extract product.

Talk to a healthcare professional if any apply

  • Pregnancy or breastfeeding
  • Use of prescription medicines, including diuretics
  • An ongoing medical condition or persistent symptoms
  • Use of a concentrated extract or combined preparation with unclear composition
  • Significant or unexpected adverse effects

Products

What changes between products?

Form differences

  • Root, leaf/herb and root + herb are distinct plant-part preparations and should not be treated as interchangeable.
  • The small human study examined a specific leaf extract over a single day; it did not establish effects for root or root + herb preparations.
  • Root monograph context should not be transferred to leaf/herb products, and root + herb monograph context should not be transferred to root-only or leaf-only products.
  • Tea, powder, capsule, tablet, extract and liquid products may differ in plant part, extraction method, composition and amount.
  • Phytochemical, laboratory and animal findings do not establish clinical efficacy for a commercial Dandelion product.

Form considerations

  • Root, leaf/herb and root + herb products should not be compared as if they were the same intervention.
  • Tea, powder, capsule, tablet, extract and liquid products may represent different materials and should not be compared solely by package size or headline amount.
  • A product listing an extract should be assessed for whether its plant part and preparation resemble the source being cited.

Plant part considerations

  • Confirm whether the product contains root, leaf/herb or both root and herb.
  • Do not apply the single-day leaf-extract finding to root or root + herb products.
  • Do not apply root monograph context to leaf/herb products, or root + herb context to root-only or leaf-only products.
  • Do not infer the plant part from the common name “Dandelion” alone.

Extract considerations

  • Record extract identity, plant part, solvent and extraction details only when the product source explicitly provides them.
  • Do not infer extraction ratios, concentration or clinical equivalence from an unspecified extract amount.

Standardization considerations

  • Record declared standardization only when genuinely disclosed and sourceable.
  • Do not invent marker-compound amounts or imply that standardization automatically means greater efficacy.

Evaluation

How to evaluate a supplement

What to check

  • Taraxacum botanical identity where disclosed
  • Plant part: root, leaf/herb or root + herb
  • Preparation: tea, powder, capsule, tablet, extract or liquid
  • Whole plant material versus extract
  • Extraction method or solvent only where explicitly disclosed
  • Amount and serving information only when genuinely disclosed
  • Whether the product is Dandelion alone or a combination formula
  • Other ingredients and label transparency
  • Identity, contaminant and batch or lot information where disclosed

Serving considerations

  • Compare the labelled preparation and amount with the relevant source without turning that comparison into a dosage recommendation.
  • A larger declared amount does not automatically mean a stronger or better-supported product.

Testing considerations

  • Look for botanical identity and plant-part information where disclosed.
  • Look for contaminant testing and batch or lot traceability where disclosed.
  • Treat testing and phytochemical-marker information as product-quality disclosure, not proof of clinical efficacy.

Label transparency

  • The botanical identity and plant part should be clear where possible.
  • Tea, powder, capsule, tablet, extract or liquid preparation details should be explicit.
  • The labelled amount and serving should be explicit when disclosed.
  • Combination ingredients should be listed.
  • Marketing language should not be treated as human clinical evidence.

Supplements

Related supplements

Sources

Authoritative sources referenced

research-reviewedLast reviewed 2026-09-20Next review 2027-09-20

Sections reviewed

overviewbotanicaltraditionalContextpreparationsresearchevidencesafetyproductEvaluationrelationshipssources

Created the canonical Dandelion Herb Profile v1 with Taraxacum officinale identity, explicit root, leaf/herb and root + herb distinctions, preparation-aware interpretation of the small single-day leaf-extract study, traditional-use context, cautious review and preclinical framing, safety limitations and product-evaluation criteria. No dosage recommendation is made.

Regulatory sources are included for context only. Regulatory status is not evidence for or against efficacy, and is not a treatment or safety recommendation.

This profile is provided for educational purposes only and is not medical advice. Traditional context and research summaries are distinguished from claims, and nothing here is a treatment recommendation. Always consult a qualified healthcare professional before using any herb, especially if you are pregnant, nursing, take medication, or have a medical condition.